sittithat tangwitthayaphum / iStock / Getty Images Plus
Data Don’t Look Good for Four COVID-19 Treatments
The World Health Organization released preliminary results on the effectiveness of four COVID-19 treatments, and they were lackluster at best. The 11,000-person trial focused on the use of Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir), and Interferon-β1a among patients with COVID-19 in 400 hospitals across the world. None of the treatments reduced mortality, decreased the need for breathing assistance, or shortened the length of hospital stay.
A preprint of results was released on October 15, with the final data scheduled for publication in The New England Journal of Medicine. Read more here.